Literature DB >> 1860554

Insulin and glucose levels and prevalence of glucose intolerance in pedigrees with multiple diabetic siblings.

S C Elbein1, T M Maxwell, M C Schumacher.   

Abstract

Hyperinsulinemia may be an early inherited marker for a defect in insulin action that subsequently results in glucose intolerance and non-insulin-dependent diabetes mellitus (NIDDM). To examine the role of hyperinsulinemia in individuals at high genetic risk for NIDDM and determine the prevalence of impaired glucose tolerance (IGT) and newly diagnosed diabetes in members of NIDDM pedigrees, we studied 310 members of 16 pedigrees ascertained for greater than or equal to 2 NIDDM siblings. Nondiabetic members of all pedigrees were examined by 75-g oral glucose tolerance test with fasting and 1-h insulin levels. Participants had height and weight recorded. Spouses of pedigree members (n = 88) served as control subjects. The spouse control subjects were older and slightly more obese than the undiagnosed pedigree members. The prevalence of IGT was 14.8% in spouses and 7.7% in pedigree members, and NIDDM was present in 11.3% of spouses and 2.3% of previously undiagnosed pedigree members. However, neither spouses nor pedigree members differed significantly from published age-specific prevalence rates for IGT or newly diagnosed NIDDM. Insulin and glucose levels were examined in pedigree members with normal glucose tolerance (NGT). Fasting insulin levels were not significantly different between spouses and NGT pedigree members. However, after adjustment for age, weight (body mass index), and sex, NGT pedigree members had higher 1-h insulin levels and higher fasting and 1-h glucose levels than spouses. These differences were also evident when pedigree members with at least 1 affected (NIDDM or IGT) parent were compared with spouses with no family history of diabetes.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1860554     DOI: 10.2337/diab.40.8.1024

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  8 in total

1.  Genetic variation in insulin receptor beta-chain exons among members of familial type 2 (non-insulin-dependent) diabetic pedigrees.

Authors:  S C Elbein; L K Sorensen
Journal:  Diabetologia       Date:  1991-10       Impact factor: 10.122

Review 2.  Genetics of insulin resistance.

Authors:  Maria M Mercado; John C McLenithan; Kristi D Silver; Alan R Shuldiner
Journal:  Curr Diab Rep       Date:  2002-02       Impact factor: 4.810

3.  Linkage disequilibrium among RFLPs at the insulin-receptor locus despite intervening Alu repeat sequences.

Authors:  S C Elbein
Journal:  Am J Hum Genet       Date:  1992-11       Impact factor: 11.025

4.  Molecular screening of the glucokinase gene in familial type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  S C Elbein; M Hoffman; H Qin; K Chiu; Y Tanizawa; M A Permutt
Journal:  Diabetologia       Date:  1994-02       Impact factor: 10.122

5.  Increased glucose effectiveness in normoglycemic but insulin-resistant relatives of patients with non-insulin-dependent diabetes mellitus. A novel compensatory mechanism.

Authors:  J E Henriksen; F Alford; A Handberg; A Vaag; G M Ward; A Kalfas; H Beck-Nielsen
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

6.  Linkage analysis of the glucokinase locus in familial type 2 (non-insulin-dependent) diabetic pedigrees.

Authors:  S C Elbein; M Hoffman; K Chiu; Y Tanizawa; M A Permutt
Journal:  Diabetologia       Date:  1993-02       Impact factor: 10.122

7.  Oxidative stress in metabolic syndrome.

Authors:  Praveen Sharma; Sandhya Mishra; Peeyush Ajmera; Sandeep Mathur
Journal:  Indian J Clin Biochem       Date:  2005-01

Review 8.  Profile of metabolic abnormalities seen in patients with type 2 diabetes mellitus and their first degree relatives with metabolic syndrome seen in Benin City, Edo state Nigeria.

Authors:  Stephen O Ogedengbe; Ignatius U Ezeani
Journal:  J Diabetes Metab Disord       Date:  2014-05-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.